English

Research and Development

SSI is one of Denmark’s largest research institutions in the health sector.
More about SSI's research and development

R and DSSI is one of Denmark’s largest research institutions in the health sector
Contract ServicesSSI provides contract work within our core activities and competences
Job and CareerRead about SSI as a workplace and meet some of our employees
EPI-NEWSNational surveillance of communicable diseases
Girl in the rain

New mission and strategy

SSI has produced a new strategy with a focus on infectious disease preparedness, biobanking and biomarkers, and research. Read more about SSI's new strategy...
Danish National Biobank

The Danish National Biobank

The Danish National Biobank gives scientists from Denmark and abroad overview and access to more than 16 million biological samples in both existing and future collections. Read more about the Danish National Biobank...
Low plasma levels of omega-3 fatty acids associated with preterm birth
03-08-2018
Pregnant women with the lowest plasma levels of long chain omega-3 (n-3) fatty acids - the kind found in fish oil - were at 10...
The 2017/18 influenza season was a very unusual one
20-06-2018
The season was very prolonged and characterised by a high number of influenza cases, among which influenza B was dominant.
The European pertussis meeting will be held at SSI in September 2018
08-05-2018
For the third time, SSI will host the annual European pertussis meeting, EUPertstrain/EUPertgenomics.

More news...

EPI-NEWS, No 27a+b - 2018
Vaccination recommendations for foreign travel
Pilgrimages to Mecca
Conclusion of vaccination series with Cervarix® in the ch...
EPI-NEWS, No 26 - 2018
Imported malaria 2017
EPI-NEWS, No 25 - 2018
Botulism outbreak in Southern Jutland
MRSA 2017
EPI-NEWS, No 23-24 - 2018
The 2017/2018 influenza season
EPI-NEWS, No 22 - 2018
Syphilis 2017

More EPI-NEWS...

Low plasma levels of omega-3 fatty acids associated with preterm birth
03-08-2018
Pregnant women with the lowest plasma levels of long chain omega-3 (n-3) fatty acids - the kind found in fish oil - were at 10 times incr...
SSI receives EUR 13.8 million grant from EDCTP to test new tuberculosis (TB) vaccine
21-03-2018
Statens Serum Institut (SSI) in Copenhagen Denmark has been granted a sum of EUR 13.8 million from the European & Developing Countries Cl...
Scientist at SSI receives a grant for further development of a vaccine against resistant enteropathogen
22-12-2017
Scientists at SSI have developed a new potential vaccine against infections from the enteropathogen, Clostridium difficile (CD).
Sweden and Finland are more successful in the fight against tuberculosis than Denmark
09-11-2017
The number of tuberculosis cases among Swedish and Finnish indigenous citizens falls faster than in Denmark shows a new Nordic survey.

More R and D News...

Available Positions:

Currently, we have no available positions.

Statens Serum Institut         

5 Artillerivej

DK 2300 Copenhagen S

T  +45 3268 3268

F  +45 3268 3868